Disease activity states of the DAPSA, a psoriatic arthritis specific instrument, are valid against functional status and structural progression | Annals of the Rheumatic Diseases
Comparison of Composite Measures of Disease Activity in Psoriatic Arthritis Using Data From an Interventional Study With Golimumab - Helliwell - 2014 - Arthritis Care & Research - Wiley Online Library
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology
Disease activity categories by Q-DAPSA vs. DAPSA | Download Scientific Diagram
Dapsa Eng | PDF
Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study - The Lancet Rheumatology
Correlation of patient‐reported routine assessment of patient index data with clinical measures of disease activity in psoriatic arthritis - Ward - 2022 - International Journal of Rheumatic Diseases - Wiley Online Library
Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study - ScienceDirect
Disease activity categories by Q-DAPSA vs. DAPSA | Download Scientific Diagram
LS mean change from baseline in (a) PASDAS, (b) DAPSA, and (c) CPDAI.... | Download Scientific Diagram
Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score | Annals of the Rheumatic Diseases
Supplementary Table 1. Calculation of DAPSA and CPDAI and CPDAI disease activity categories (modified from [1,2]) Disease Activi
DAPSA versus cDAPSA: Do we need to use CRP? | Annals of the Rheumatic Diseases
Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review. | Semantic Scholar
Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World
PDF) Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study
Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort | Annals of the Rheumatic Diseases
Response to: 'To DAPSA or not to DAPSA? That is not the question' by Schoels et al | Annals of the Rheumatic Diseases
Digital Tools for Assessing Disease Severity in Dermatology. - Abstract - Europe PMC
The state of the art—psoriatic arthritis outcome assessment in clinical trials and daily practice - The Lancet Rheumatology
RheumaHelper - Apps on Google Play
MDA Versus DAPSA: Applicability in a Real World - ACR Meeting Abstracts
DAPSA (Disease Activity in PSoriatic Arthritis) Score DAPSA = TJ + SJ + CRP + Activity + Pain =
